Labcorp Holdings ( ($LH) ) has provided an update. On December 10, 2025, Labcorp Holdings announced the retirement of Dr. D. Gary Gilliland from ...

The "Pharmaceutical Safety Assessment Global Market Report 2025" has been added to ResearchAndMarkets.com's offering.The pharmaceutical safety assessment market has demonstrated significant growth, ...

Prominent companies operating in the global drug discovery services market include: • Charles River Laboratories (US) • ...

Global Anatomic Pathology Market OverviewThe global anatomic pathology market is poised for a strong growth trajectory, expected to expand at a CAGR of nearly 8% during the forecast period. This ...

Acquisitions are part of deal acceleration in Artificial Intelligence, Digital Clinical Research, and Observability Technologies. Marvell ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

LNK01006 recently received IND clearance from the FDA to initiate first-in-human studies in the US. Formation Bio plans to initiate a Phase 1 study in the first half of 2026, reflecting the company's ...

Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. | Rival ...

The FDA vaccine approval road map proposes longer trials and stricter evidence to improve vaccine safety and effectiveness oversight.

PharmAla is furthermore pleased to announce that it has completed its first delivery of its Australian-made product to the Orygen Institute. The shipment represents the second such shipment made by ...

Eli Lilly plans to start work next year on a facility that will produce orforglipron, officials announced Tuesday in Huntsville.